Browsing Breast Cancer Research by author "Battisti, Nicolo"
Now showing items 1-20 of 24
-
Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group.
Battisti, NML; Mislang, AR; Cooper, L; O'Donovan, A; Audisio, RA; et al. (ELSEVIER, 2020-11-01)The COVID-19 pandemic poses a barrier to equal and evidence-based management of cancer in older adults. The International Society of Geriatric Oncology (SIOG) formed a panel of experts to develop consensus recommendations ... -
Biological aspects of aging that influence response to anticancer treatments.
Crimmin, J; Fulop, T; Battisti, NML (LIPPINCOTT WILLIAMS & WILKINS, 2021-03-01)PURPOSE OF REVIEW: Cancer is a disease of older adults, where fitness and frailty are a continuum. This aspect poses unique challenges to the management of cancer in this population. In this article, we review the biological ... -
Breast cancer and common malignancies in older adults
Battisti, N (Institute of Cancer Research (University Of London), 2022-08-08)Cancer is increasingly a diseases of older adults. However, they are heterogeneous and life expectancy and tolerance to stressors may vary greatly within this age group. Comorbidities, functional impairments, malnutrition, ... -
Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer.
Battisti, NML; Reed, MWR; Herbert, E; Morgan, JL; Collins, KA; et al. (ELSEVIER SCI LTD, 2021-02-01)INTRODUCTION: Older patients with early breast cancer (EBC) derive modest survival benefit from chemotherapy but have increased toxicity risk. Data on the impact of chemotherapy for EBC on quality of life in older patients ... -
Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer.
Ring, A; Battisti, NML; Reed, MWR; Herbert, E; Morgan, JL; et al. (SPRINGERNATURE, 2021-07-20)BACKGROUND: Chemotherapy improves outcomes for high risk early breast cancer (EBC) patients but is infrequently offered to older individuals. This study determined if there are fit older patients with high-risk disease who ... -
Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective.
Desideri, I; Pilleron, S; Battisti, NML; Gomes, F; de Glas, N; et al. (ELSEVIER, 2020-09-01)The ongoing coronavirus disease 2019 (COVID-19) pandemic has affected millions of people in over 180 territories, causing a significant impact on healthcare systems globally. Older adults, as well as people living with ... -
Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic review.
Battisti, NML; De Glas, N; Soto-Perez-de-Celis, E; Liposits, G; Bringuier, M; et al. (ELSEVIER SCI LTD, 2022-09-01)BACKGROUND: The benefit of chemotherapy for older patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer (EBC) is a key area of debate. Gene expression ... -
COVID-19 vaccines in older adults with cancer: a Young International Society of Geriatric Oncology perspective.
Loh, KP; Soto-Perez-de-Celis, E; Mislang, AR; Chan, W-L; Battisti, NML (ELSEVIER, 2021-05-06) -
Do we still need breast cancer screening in the era of targeted therapies and precision medicine?
Trimboli, RM; Giorgi Rossi, P; Battisti, NML; Cozzi, A; Magni, V; et al. (SPRINGER WIEN, 2020-09-25)Breast cancer (BC) is the most common female cancer and the second cause of death among women worldwide. The 5-year relative survival rate recently improved up to 90% due to increased population coverage and women's ... -
Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper.
Pergolotti, M; Battisti, NML; Padgett, L; Sleight, AG; Abdallah, M; et al. (ELSEVIER, 2020-03-01)Cancer-related cognitive decline (CRCD) may have particularly significant consequences for older adults, impacting their functional and physical abilities, level of independence, ability to make decisions, treatment ... -
Geriatric Oncology as an Unmet Workforce Training Need in the United Kingdom-A Narrative Review by the British Oncology Network for Undergraduate Societies (BONUS) and the International Society of Geriatric Oncology (SIOG) UK Country Group.
Khoury, EG; Nuamek, T; Heritage, S; Fulton-Ward, T; Kucharczak, J; et al. (MDPI, 2023-09-28)Cancer is a disease associated with ageing. Managing cancer in older adults may prove challenging owing to pre-existing frailty, comorbidity, and wider holistic needs, as well as the unclear benefits and harms of standard ... -
Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper.
Gomes, F; Wong, M; Battisti, NML; Kordbacheh, T; Kiderlen, M; et al. (SPRINGERNATURE, 2020-09-15)Immunotherapy with checkpoint inhibitors against programmed cell death receptor (PD-1) and programmed cell death ligand (PD-L1) has been implemented in the treatment pathway of patients with non-small cell lung cancer ... -
International Survey on Frailty Assessment in Patients with Cancer.
Banna, GL; Cantale, O; Haydock, MM; Battisti, NML; Bambury, K; et al. (OXFORD UNIV PRESS, 2022-10-01)BACKGROUND: Frailty negatively affects the outcomes of patients with cancer, and its assessment might vary widely in the real world. The objective of this study was to explore awareness and use of frailty screening tools ... -
Observational cohort study in older women with early breast cancer: Use of radiation therapy and impact on health-related quality of life and mortality.
Battisti, NML; Hatton, MQ; Reed, MWR; Herbert, E; Morgan, JL; et al. (ELSEVIER IRELAND LTD, 2021-06-16)BACKGROUND: Radiotherapy reduces in-breast recurrence risk in early breast cancer (EBC) in older women. This benefit may be small and should be balanced against treatment effect and holistic patient assessment. This study ... -
Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO).
Muscaritoli, M; Bar-Sela, G; Battisti, NML; Belev, B; Contreras-Martínez, J; et al. (MDPI, 2023-01-06)Nutritional issues, including malnutrition, low muscle mass, sarcopenia (i.e., low muscle mass and strength), and cachexia (i.e., weight loss characterized by a continuous decline in skeletal muscle mass, with or without ... -
Perspectives on geriatric oncology research presented at the 2019 San Antonio Breast Cancer Symposium.
Battisti, NML; Lok, WCW; Subbiah, I; Okonji, D; Desideri, I; et al. (ELSEVIER, 2020-05-01) -
Perspectives on Geriatric Oncology Research Presented at the 2020 San Antonio Breast Cancer Symposium.
Hill, A; Chan, W-L; Shih, Y-Y; Tiwari, A; Monteiro, AR; et al. (ELSEVIER, 2021-03-27) -
Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies: A National Registry Dataset Analysis.
Battisti, NML; Welch, CA; Sweeting, M; de Belder, M; Deanfield, J; et al. (ELSEVIER, 2022-06-01)BACKGROUND: Although a common challenge for patients and clinicians, there is little population-level evidence on the prevalence of cardiovascular disease (CVD) in individuals diagnosed with potentially curable cancer. ... -
Safety and efficacy of T-DM1 in 128 patients with advanced HER2+breast cancer: The Royal Marsden experience
Battisti, NML; Lee, KA; Shepherd, S; Rogerson, F; Mohammed, K; et al. (OXFORD UNIV PRESS, 2019-10-01) -
Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experience.
Battisti, NML; Rogerson, F; Lee, K; Shepherd, S; Mohammed, K; et al. (Elsevier BV, 2020-01-01)BACKGROUND: Ado-trastuzumab emtansine (T-DM1) is standard of care for patients with advanced HER2+ breast cancer who relapse within 6 months of adjuvant trastuzumab or progress on first-line anti-HER2 therapy. We evaluated ...